Section of Cardiovascular Medicine.
Cardiology Department, Saint Vincent Hospital, Worcester, Massachusetts.
Am J Cardiol. 2022 Jan 1;162:100-104. doi: 10.1016/j.amjcard.2021.09.013. Epub 2021 Oct 28.
Implantable loop recorder (ILR) is recommended to detect subclinical atrial fibrillation (AF) after cryptogenic stroke; however, the clinical outcomes of this practice is unclear. We conducted a systematic review and meta-analysis of randomized controlled trials to evaluate 12-month AF detection, change in oral anticoagulation (OAC), and recurrent stroke in ILR versus usual care after ischemic stroke. We searched Medline, Embase, Web of Science, Cochrane Library for randomized controlled trials comparing ILR with usual care after any ischemic stroke. Primary outcomes were cumulative AF detection and recurrent stroke (ischemic or hemorrhagic) or transient ischemic attack over 12 months. Secondary outcome was OAC initiation. Meta-analysis was performed with Mantel-Haenszel pooled odds ratios (ORs) and random effects models. Of 200 identified articles, 3 trials were included (1,233 participants). Cryptogenic stroke and underlying AF included cryptogenic stroke only, stroke of known cause and underlying-AF included small or large vessel stroke only, and post embolic rhythm detection with implantable vs external monitoring included all ischemic strokes. The 12-month AF detection was 13% in the ILR group and 2.4% in controls. ILR was more likely to detect AF compared with usual care (OR 5.8, 95% confidence interval 3.2 to 10.2). Stroke or transient ischemic attack occurred in 7% with ILR and 9% with usual care (OR 0.8, 95% confidence interval 0.5 to 1.2). In patients with detected AF, 97% and 100% were started on OAC in cryptogenic stroke and underlying AF and post embolic rhythm detection with implantable vs external monitoring, respectively, compared with 68% in stroke of known cause and underlying-AF. In conclusion, ILR was superior to usual care in AF detection, but the relative low incidence of AF and the nondifferential risk of stroke between the ILR and usual care arms may suggest that most patients do not benefit from ILR implantation. Further studies are warranted to understand if patient selection can be improved to increase the diagnostic yield of ILR.
植入式循环记录仪(ILR)被推荐用于检测隐源性卒中后的亚临床房颤(AF);然而,这种做法的临床结果尚不清楚。我们进行了系统评价和荟萃分析,以评估 ILR 与常规护理相比,在缺血性卒中后 12 个月时 AF 的检出率、口服抗凝药物(OAC)的变化以及复发性卒中。我们检索了 Medline、Embase、Web of Science、Cochrane 图书馆中比较任何类型的缺血性卒中后 ILR 与常规护理的随机对照试验。主要结局是 12 个月时累积 AF 检出率以及复发性卒中(缺血性或出血性)或短暂性脑缺血发作。次要结局是 OAC 的启动。采用 Mantel-Haenszel 汇总比值比(OR)和随机效应模型进行荟萃分析。在 200 篇确定的文章中,有 3 项试验被纳入(1233 名参与者)。隐源性卒中伴或不伴 AF 组包括仅隐源性卒中、已知病因的卒中伴或不伴 AF 组包括小血管或大血管卒中,以及植入式与外部监测的栓塞后节律检测组包括所有缺血性卒中。ILR 组 12 个月时的 AF 检出率为 13%,对照组为 2.4%。与常规护理相比,ILR 更有可能检测到 AF(OR 5.8,95%置信区间 3.2 至 10.2)。ILR 组发生卒中和短暂性脑缺血发作的比例为 7%,对照组为 9%(OR 0.8,95%置信区间 0.5 至 1.2)。在检测到 AF 的患者中,隐源性卒中伴或不伴 AF 以及栓塞后节律检测的植入式与外部监测相比,分别有 97%和 100%的患者开始使用 OAC,而在已知病因的卒中伴 AF 中,只有 68%的患者开始使用 OAC。总之,ILR 在 AF 检出方面优于常规护理,但 AF 的相对低发生率以及 ILR 和常规护理组之间卒中的非差异风险可能表明,大多数患者并未从 ILR 植入中获益。需要进一步的研究来了解是否可以通过选择患者来提高 ILR 的诊断效果。